We are live on ! Find out more
MCP

Martin Capital Partners Portfolio holdings

AUM $272M
1-Year Est. Return 19.09%
This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+19.09%
3 Year Est. Return
+35.19%
5 Year Est. Return
+47.96%
10 Year Est. Return
–
AUM
$169M
AUM Growth
+$20.6M
Cap. Flow
+$12.7M
Cap. Flow %
7.52%
Top 10 Hldgs %
32.59%
Holding
63
New
10
Increased
44
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$2.93M
2
MRK icon
Merck
MRK
+$2.43M
3
GILD icon
Gilead Sciences
GILD
+$1.68M
4
XOM icon
ExxonMobil
XOM
+$1.51M
5
MSM icon
MSC Industrial Direct
MSM
+$1.38M

Top Sells

Rank Stock Value
1
WBK
Westpac Banking Corporation
WBK
+$2.82M
2
GSK icon
GSK
GSK
+$2.07M
3
AAPL icon
Apple
AAPL
+$1.54M
4
T icon
AT&T
T
+$1.46M
5
MSFT icon
Microsoft
MSFT
+$525K

Sector Composition

Rank Sector Weight
1 Healthcare 17.23%
2 Financials 16.38%
3 Technology 12.35%
4 Consumer Staples 11.19%
5 Energy 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMC icon
26
Omnicom Group
OMC
$21.6B
$3.38M 2%
41,676
+17,001
+69% +$1.33M
GSK icon
27
GSK
GSK
$104B
$3.36M 1.98%
57,167
-37,282
-39% -$2.07M
VTR icon
28
Ventas
VTR
$48B
$3.35M 1.98%
58,032
+5,824
+11% +$366K
EMN icon
29
Eastman Chemical
EMN
$8B
$3.34M 1.97%
42,157
+2,812
+7% +$216K
WSM icon
30
Williams-Sonoma
WSM
$26.9B
$3.27M 1.94%
89,202
+4,758
+6% +$165K
K
31
DELISTED
Kellanova
K
$3.14M 1.86%
+48,411
New +$2.93M
PEP icon
32
PepsiCo
PEP
$190B
$2.7M 1.59%
19,729
+807
+4% +$110K
MRK icon
33
Merck
MRK
$322B
$2.56M 1.52%
+29,558
New +$2.43M
QCOM icon
34
Qualcomm
QCOM
$155B
$2.55M 1.51%
28,869
+1,057
+4% +$88.4K
T icon
35
AT&T
T
$159B
$2.48M 1.46%
83,852
-50,672
-38% -$1.46M
AXP icon
36
American Express
AXP
$227B
$2.46M 1.45%
19,771
+702
+4% +$83.9K
PFG icon
37
Principal Financial Group
PFG
$24.3B
$2.45M 1.45%
44,562
+3,286
+8% +$180K
RTN
38
DELISTED
Raytheon Company
RTN
$2.34M 1.38%
10,654
+288
+3% +$60.9K
D icon
39
Dominion Energy
D
$60.8B
$2.33M 1.38%
28,160
+824
+3% +$67.3K
SHY icon
40
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$2.31M 1.36%
27,253
+1,054
+4% +$89.3K
PEG icon
41
Public Service Enterprise Group
PEG
$38.2B
$2.13M 1.26%
35,980
+1,428
+4% +$86.6K
STIP icon
42
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
$1.85M 1.1%
18,397
+429
+2% +$43K
IEI icon
43
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
$1.21M 0.71%
9,596
-59
-0.6% -$7.45K
SCHD icon
44
Schwab US Dividend Equity ETF
SCHD
$103B
$684K 0.4%
35,433
+3,855
+12% +$72.2K
PAI
45
Western Asset Investment Grade Income Fund
PAI
$113M
$556K 0.33%
35,842
– –
FAX
46
DELISTED
abrdn Asia-Pacific Income Fund
FAX
$453K 0.27%
17,768
– –
BWZ icon
47
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$269M
$429K 0.25%
13,912
+25
+0.2% +$763
CLX icon
48
Clorox
CLX
$11.6B
$366K 0.22%
2,383
+797
+50% +$119K
DGX icon
49
Quest Diagnostics
DGX
$25.7B
$317K 0.19%
2,969
+942
+46% +$98.2K
IRM icon
50
Iron Mountain
IRM
$36.4B
$311K 0.18%
9,773
+3,224
+49% +$106K
1
2
3

Similar funds

SC
Seldon Capital San Francisco, California $272M AUM 90.68% 1-Year Est. Return
SC
Swan Capital Pensacola, Florida $272M AUM 14.84% 1-Year Est. Return
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM
AGP
Autumn Glory Partners Dallas, Texas $272M AUM 20.37% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return

Martin Capital Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Martin Capital Partners held 63 positions worth $169M, up 14% from $149M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Martin Capital Partners deployed $12.7M of net new capital in Q4 2019, opening 10 new positions and adding to 44 existing holdings. Its largest new stake was Kellanova: 48,411 shares worth $3.14M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was GSK, an estimated $2.07M trimmed.

  • Martin Capital Partners's largest Q4 2019 buy was Kellanova: 48,411 shares worth $3.14M.
  • Martin Capital Partners added most to Gilead Sciences in Q4 2019, an estimated $1.68M increase.
  • Martin Capital Partners's biggest Q4 2019 reduction was GSK, cutting an estimated $2.07M.
  • Martin Capital Partners fully exited Westpac Banking Corporation in Q4 2019, selling an estimated $2.82M.
  • Martin Capital Partners's ten largest holdings make up 33% of its $169M portfolio in Q4 2019.
  • Martin Capital Partners opened 10 new positions and closed 1 in Q4 2019.
  • Martin Capital Partners's portfolio value rose 14% quarter-over-quarter to $169M.

Based on Martin Capital Partners's 13F filing for Q4 2019, filed 31 Jan 2020.